Estrogen-induced protection against experimental autoimmune encephalomyelitis is abrogated in the absence of B cells

Sheetal Bodhankar, Chunhe Wang, Arthur Vandenbark, Halina Offner

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Increased remissions in multiple sclerosis (MS) during pregnancy suggest that elevated levels of sex steroids exert immunoregulatory activity. Estrogen (E2=17β-estradiol) protects against experimental autoimmune encephalomyelitis (EAE), but the cellular basis for E2-induced protection remains unclear. Studies demonstrate that depletion of B cells prior to induction of EAE exacerbates disease severity, implicating regulatory B cells. We thus evaluated pathogenic and E2-induced protective mechanisms in B-cell-deficient (μMT-/-) mice. EAE-protective effects of E2 were abrogated in μMT-/- mice, with no reduction in disease severity, cellular infiltration or pro-inflammatory factors in the central nervous system compared to untreated controls. E2 treatment of WT mice selectively upregulated expression of PD-L1 on B cells and increased the percentage of IL-10-producing CD1dhighCD5+ regulatory B cells. Upregulation of PD-L1 was critical for E2-mediated protection since E2 did not inhibit EAE in PD-L1-/- mice. Direct treatment of B cells with E2 significantly reduced proliferation of MOG35-55-specific T cells that required estrogen receptor-α (ERα). These results demonstrate, for the first time, a requirement for B cells in E2-mediated protection against EAE involving direct E2 effects on regulatory B cells mediated through ERα and the PD-1/PD-L1 negative co-stimulatory pathway. E2-primed B cells may represent an important regulatory mechanism in MS and have strong implications for women receiving current MS therapies that cause B-cell depletion.

Original languageEnglish (US)
Pages (from-to)1165-1175
Number of pages11
JournalEuropean Journal of Immunology
Volume41
Issue number4
DOIs
StatePublished - Apr 2011

Fingerprint

Autoimmune Experimental Encephalomyelitis
Estrogens
B-Lymphocytes
Regulatory B-Lymphocytes
Multiple Sclerosis
Estrogen Receptor alpha
Estrogen Receptors
Interleukin-10
Estradiol
Up-Regulation
Therapeutics
Central Nervous System
Steroids
T-Lymphocytes
Pregnancy

Keywords

  • EAE
  • Estrogen
  • MS
  • Regulatory B cells

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Estrogen-induced protection against experimental autoimmune encephalomyelitis is abrogated in the absence of B cells. / Bodhankar, Sheetal; Wang, Chunhe; Vandenbark, Arthur; Offner, Halina.

In: European Journal of Immunology, Vol. 41, No. 4, 04.2011, p. 1165-1175.

Research output: Contribution to journalArticle

@article{8817e5de92ba4b3bab258a501812ba2f,
title = "Estrogen-induced protection against experimental autoimmune encephalomyelitis is abrogated in the absence of B cells",
abstract = "Increased remissions in multiple sclerosis (MS) during pregnancy suggest that elevated levels of sex steroids exert immunoregulatory activity. Estrogen (E2=17β-estradiol) protects against experimental autoimmune encephalomyelitis (EAE), but the cellular basis for E2-induced protection remains unclear. Studies demonstrate that depletion of B cells prior to induction of EAE exacerbates disease severity, implicating regulatory B cells. We thus evaluated pathogenic and E2-induced protective mechanisms in B-cell-deficient (μMT-/-) mice. EAE-protective effects of E2 were abrogated in μMT-/- mice, with no reduction in disease severity, cellular infiltration or pro-inflammatory factors in the central nervous system compared to untreated controls. E2 treatment of WT mice selectively upregulated expression of PD-L1 on B cells and increased the percentage of IL-10-producing CD1dhighCD5+ regulatory B cells. Upregulation of PD-L1 was critical for E2-mediated protection since E2 did not inhibit EAE in PD-L1-/- mice. Direct treatment of B cells with E2 significantly reduced proliferation of MOG35-55-specific T cells that required estrogen receptor-α (ERα). These results demonstrate, for the first time, a requirement for B cells in E2-mediated protection against EAE involving direct E2 effects on regulatory B cells mediated through ERα and the PD-1/PD-L1 negative co-stimulatory pathway. E2-primed B cells may represent an important regulatory mechanism in MS and have strong implications for women receiving current MS therapies that cause B-cell depletion.",
keywords = "EAE, Estrogen, MS, Regulatory B cells",
author = "Sheetal Bodhankar and Chunhe Wang and Arthur Vandenbark and Halina Offner",
year = "2011",
month = "4",
doi = "10.1002/eji.201040992",
language = "English (US)",
volume = "41",
pages = "1165--1175",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "4",

}

TY - JOUR

T1 - Estrogen-induced protection against experimental autoimmune encephalomyelitis is abrogated in the absence of B cells

AU - Bodhankar, Sheetal

AU - Wang, Chunhe

AU - Vandenbark, Arthur

AU - Offner, Halina

PY - 2011/4

Y1 - 2011/4

N2 - Increased remissions in multiple sclerosis (MS) during pregnancy suggest that elevated levels of sex steroids exert immunoregulatory activity. Estrogen (E2=17β-estradiol) protects against experimental autoimmune encephalomyelitis (EAE), but the cellular basis for E2-induced protection remains unclear. Studies demonstrate that depletion of B cells prior to induction of EAE exacerbates disease severity, implicating regulatory B cells. We thus evaluated pathogenic and E2-induced protective mechanisms in B-cell-deficient (μMT-/-) mice. EAE-protective effects of E2 were abrogated in μMT-/- mice, with no reduction in disease severity, cellular infiltration or pro-inflammatory factors in the central nervous system compared to untreated controls. E2 treatment of WT mice selectively upregulated expression of PD-L1 on B cells and increased the percentage of IL-10-producing CD1dhighCD5+ regulatory B cells. Upregulation of PD-L1 was critical for E2-mediated protection since E2 did not inhibit EAE in PD-L1-/- mice. Direct treatment of B cells with E2 significantly reduced proliferation of MOG35-55-specific T cells that required estrogen receptor-α (ERα). These results demonstrate, for the first time, a requirement for B cells in E2-mediated protection against EAE involving direct E2 effects on regulatory B cells mediated through ERα and the PD-1/PD-L1 negative co-stimulatory pathway. E2-primed B cells may represent an important regulatory mechanism in MS and have strong implications for women receiving current MS therapies that cause B-cell depletion.

AB - Increased remissions in multiple sclerosis (MS) during pregnancy suggest that elevated levels of sex steroids exert immunoregulatory activity. Estrogen (E2=17β-estradiol) protects against experimental autoimmune encephalomyelitis (EAE), but the cellular basis for E2-induced protection remains unclear. Studies demonstrate that depletion of B cells prior to induction of EAE exacerbates disease severity, implicating regulatory B cells. We thus evaluated pathogenic and E2-induced protective mechanisms in B-cell-deficient (μMT-/-) mice. EAE-protective effects of E2 were abrogated in μMT-/- mice, with no reduction in disease severity, cellular infiltration or pro-inflammatory factors in the central nervous system compared to untreated controls. E2 treatment of WT mice selectively upregulated expression of PD-L1 on B cells and increased the percentage of IL-10-producing CD1dhighCD5+ regulatory B cells. Upregulation of PD-L1 was critical for E2-mediated protection since E2 did not inhibit EAE in PD-L1-/- mice. Direct treatment of B cells with E2 significantly reduced proliferation of MOG35-55-specific T cells that required estrogen receptor-α (ERα). These results demonstrate, for the first time, a requirement for B cells in E2-mediated protection against EAE involving direct E2 effects on regulatory B cells mediated through ERα and the PD-1/PD-L1 negative co-stimulatory pathway. E2-primed B cells may represent an important regulatory mechanism in MS and have strong implications for women receiving current MS therapies that cause B-cell depletion.

KW - EAE

KW - Estrogen

KW - MS

KW - Regulatory B cells

UR - http://www.scopus.com/inward/record.url?scp=79953045436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953045436&partnerID=8YFLogxK

U2 - 10.1002/eji.201040992

DO - 10.1002/eji.201040992

M3 - Article

C2 - 21413005

AN - SCOPUS:79953045436

VL - 41

SP - 1165

EP - 1175

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 4

ER -